SCHEMBL3982265

SCHEMBL3982265

CN1CCN(C(=O)c2nn(Cc3ccc(F)c(Cl)c3)c(=O)c3c(O)c4n(c23)CCN(C)C4=O)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.36
ALDH1A1 P00352 3/20 0.35
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
KMT2A Q03164 2/20 0.35
HRH4 Q9H3N8 1/20 0.34
SOS1 Q07889 1/20 0.34
FABP6 P51161 1/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
HTT P42858 2/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3R2 O00459 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
PIK3R5 Q8WYR1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3985369 0.94 LMNA (0.36) PARP1ALDH1A1MAPTLMNATSHR
SCHEMBL3981550 0.93 PIK3CD (0.33) PARP1ALDH1A1MAPTLMNATSHR
SCHEMBL3983968 0.93 PIK3CD (0.39) PARP1ALDH1A1MAPTTSHRPIK3CD
SCHEMBL3985220 0.92 PARP1 (0.41) PARP1ALDH1A1MAPTLMNATSHR
SCHEMBL1387060 0.90 ALDH1A1 (0.36) PARP1ALDH1A1MAPTLMNATSHR
SCHEMBL3987232 0.89 PTGER4 (0.35) PIK3CA
SCHEMBL3988126 0.89 PTGER4 (0.34) PIK3CDPIK3CAPIK3CB
SCHEMBL3982488 0.87 PTGER4 (0.33) PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL3984446 0.87 PTGER4 (0.37) PIK3CA
SCHEMBL3987210 0.86 PDE4A (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US claimed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US claimed
EP-1756114-B1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME (US) 2014-11-19 EP disclosed
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US disclosed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287394-A1 Hiv Integrase Inhibitors DHPS, DPYD, TYMP PARP1 196/4885ALDH1A1 913/4885MAPT 3743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.